Download PDF
Thromb Haemost 1991; 66(02): 189-194
DOI: 10.1055/s-0038-1646388
Review Article
Schattauer GmbH Stuttgart

Vitronectin: A New Molecular Connection in Haemostasis[*]

Klaus T Preissner
1   The Department of Haemostasis Research, Kerckhoff-Klinik, Max-Planck-Gesellschaft, Bad Nauheim, FRG
,
Dieter Jenne
2   The Institute for Biochemistry, University of Lausanne, Epalinges, Switzerland
› Author Affiliations
Further Information

Publication History

Received 31 December 1990

Accepted 14 March 1991

Publication Date:
25 July 2018 (online)

  PDF Download  Permissions and Reprints

*Dedicated to Prof. Dr. Norbert Heimburger on the occasion of his 65th birthday.


 

  • References

  • 1 Holmes R. Preparation from human serum of an alpha-one protein which induces the immediate growth of unadapted cells in vitro. J Cell Biol 1967; 32: 297-308
    CrossrefPubMedGoogle Scholar
  • 2 Hayman EG, Engvall E, A'Hearn E, Barnes D, Pierschbacher M, Ruoslahti E. Cell attachment of replicas of SDS polyacrylamide gels reveals two adhesive plasma proteins. J Cell Biol 1982; 95: 20-3
    CrossrefPubMedGoogle Scholar
  • 3 Jenne D, Stanley KK. Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J 1985; 4: 3153-7
    PubMedGoogle Scholar
  • 4 Preissner KT, Heimburger N, Anders E, Müller-Berghaus G. Physicochemical, immunochemical and functional comparison of human S-protein and vitronectin. Evidence for the identity of both plasma proteins. Biochem Biophys Res Commun 1986; 134: 951-6
    PubMedGoogle Scholar
  • 5 Tomasini BR, Mosher DF. On the identity of vitronectin and S-protein: Immunological crossreactivity and functional studies. Blood 1986; 68: 737-42
    PubMedGoogle Scholar
  • 6 Tomasini BR, Mosher DF. Vitronectin.. Prog Hemostas Thromb 1990; 10: (in press).
    PubMedGoogle Scholar
  • 7 Preissner KT, Holzhüter S, Justus C, Müller-Berghaus G. Identification and partial characterization of platelet vitronectin: Evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 1989; 74: 1989-96
    PubMedGoogle Scholar
  • 8 Parker CJ, Stone OL, White VF, Bernshaw NJ. Vitronectin (S-protein) is associated with platelets. Br J Haematol 1989; 71: 245-52
    CrossrefPubMedGoogle Scholar
  • 9 Hetland G, Pettersen HB, Mollnes TE, Johnson E. S-protein is synthesized by human monocytes and macrophages in vitro. Scand J Immunol 1989; 29: 15-21
    CrossrefPubMedGoogle Scholar
  • 10 Kanz L, Löhr GW, Preissner KT. Identification of human megakaryocyte vitronectin/S-protein.. Blood 1988; 72 (Suppl. 1) 327a
    PubMedGoogle Scholar
  • 11 Hayman EG, Pierschbacher MD, Ohgren Y, Ruoslahti E. Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA 1983; 80: 4003-7
    CrossrefPubMedGoogle Scholar
  • 12 Dahlbôck K, Löfberg H, Alumets H, Dahlbôck B. Immunohistochemical demonstration of age-related deposition of vitronectin (S-protein of complement) and terminal complement complex on dermal elastic fibers. J Invest Dermatol 1989; 92: 727-33
    CrossrefPubMedGoogle Scholar
  • 13 Dahlbôck K, Löfberg H, Dahlbôck B. Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney. Histochemistry 1987; 87: 511-5
    CrossrefPubMedGoogle Scholar
  • 14 Falk RJ, Podack E, Dalmasso AP, Jennette JC. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol 1987; 127: 182-90
    PubMedGoogle Scholar
  • 15 Guettier C, Hinglais N, Bruneval P, Kazatchkine M, Bariety J, Camillieri J-P. Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch A Pathol Anat 1989; 414: 309-13
    CrossrefPubMedGoogle Scholar
  • 16 Sato R, Komine Y, Imanaka T, Takano TJ. Monoclonal antibody EMR 1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis. Isolation and characterization of a cDNA clone for the antigen. J Biol Chem 1990; 265: 21232-6
    PubMedGoogle Scholar
  • 17 Conlan MG, Tomasini BR, Schultz RL, Mosher DF. Plasma vitronectin polymorphism in normal subjects and patients with disseminated intravascular coagulation. Blood 1988; 72: 185-90
    PubMedGoogle Scholar
  • 18 Kemkes-Matthes B, Preissner KT, Langenscheidt F, Matthes KJ, Müller-Berghaus G. S protein/vitronectin in chronic liver diseases: Correlations with serum cholinesterase, coagulation factor X and complement component C3. Eur J Haematol 1987; 39: 161-5
    PubMedGoogle Scholar
  • 19 Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 1985; 4: 2519-24
    PubMedGoogle Scholar
  • 20 Jenne D, Stanley KK. Nucleotide sequence and organization of the human S-protein gene: repeating peptide motifs in the "pexin" family and a model for their evolution. Biochemistry 1987; 26: 6735-42
    CrossrefPubMedGoogle Scholar
  • 21 Patthy L. Detecting distant homologies of mosaic proteins. Analysis of the sequences of thrombomodulin, thrombospondin, complement components C9, C8-alpha and C8-p, vitronectin and plasma cell membrane glycoprotein PC-1. J Mol Biol 1988; 202: 689-96
    PubMedGoogle Scholar
  • 22 Ginsberg MH, Loftus JC, Plow EF. Cytoadhesins, integrins, and platelets. Thromb Haemostas 1988; 59: 1-6
    PubMedGoogle Scholar
  • 23 Cheresh DA, Spiro RC. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor.. J Biol Chem 1987; 262: 17703-11
    PubMedGoogle Scholar
  • 24 Bale MD, Wohlfahrt LA, Mosher DF, Tomasini B, Sutton RC. Identification of vitronectin as a major plasma protein adsorbed on polymer surfaces of different copolymer composition. Blood 1989; 74: 2698-706
    PubMedGoogle Scholar
  • 25 Underwood PA, Bennett FA. A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J Cell Sci 1989; 93: 641-9
    PubMedGoogle Scholar
  • 26 Hayman EG, Pierschbacher MD, Suzuki S, Ruoslahti E. Vitronectin – a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res 1985; 160: 245-58
    CrossrefPubMedGoogle Scholar
  • 27 Ruoslahti E, Suzuki S, Hayman EG, Ill CR, Pierschbacher MD. Purification and characterization of vitronectin. Methods Enzymol 1987; 144: 430-7
    PubMedGoogle Scholar
  • 28 Jenne D, Hille A, Stanley KK, Huttner WB. Sulfation of two tyrosine-residues in human complement S-protein (vitronectin). Eur J Biochem 1989; 185: 391-5
    CrossrefPubMedGoogle Scholar
  • 29 Hunt LT, Barker WC, Chen HR. A domain structure common to hemopexin, vitronectin, interstitial collagenase, and a collagenase homologue. Prot Seq Data Anal 1987; 1: 21-6
    PubMedGoogle Scholar
  • 30 Smith A, Tatum FM, Muster P, Burch MK, Morgan T. Importance of ligand-induced conformational changes in hemopexin for receptor-mediated heme transport. J Biol Chem 1988; 263: 5224-9
    PubMedGoogle Scholar
  • 31 Preissner KT, Müller-Berghaus G. Neutralisation and binding of heparin by S protein/vitronectin in the inhibition of factor Xa by antithrombin III. Involvement of an inducible heparin binding domain of S protein/vitronectin. J Biol Chem 1987; 262: 12247-53
    PubMedGoogle Scholar
  • 32 Suzuki S, Pierschbacher MD, Hayman EG, Nguyen K, Ohgren Y, Ruoslahti E. Domain structure of vitronectin. J Biol Chem 1984; 259: 15307-14
    PubMedGoogle Scholar
  • 33 Barnes DW, Reing JE, Amos B. Heparin-binding properties of human serum spreading factor. J Biol Chem 1985; 260: 9117-22
    PubMedGoogle Scholar
  • 34 Skoorstengaard K, Halkier T, Hojrup P, Mosher D. Sequence location of a putative transglutaminase cross-linking site in human vitronectin. FEBS Lett 1990; 262: 269-74
    CrossrefPubMedGoogle Scholar
  • 35 Dahlbôck B, Podack ER. Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. Biochemistry 1985; 24: 2368-74
    PubMedGoogle Scholar
  • 36 Preissner KT, Wassmuth R, Müller-Berghaus G. Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J 1985; 231: 349-55
    CrossrefPubMedGoogle Scholar
  • 37 Hildebrand A, Preissner KT, Müller-Berghaus G, Teschemacher H. A novel beta-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for β-endorphin upon interaction with heparin or surfaces. J Biol Chem 1989; 264: 15429-34
    PubMedGoogle Scholar
  • 38 Tomasini B, Mosher DF. Conformational states of vitronectin: Preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. Blood 1988; 72: 903-12
    PubMedGoogle Scholar
  • 39 Sane DC, Moser TL, Parker CJ, Seiffert D, Loskutoff DJ, Greenberg CS. Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers. J Biol Chem 1990; 265: 3543-8
    PubMedGoogle Scholar
  • 40 Preissner KT, Grulich-Henn J, Ehrlich HJ, Declerck P, Justus C, Collen D, Pannekoek H, Müller-Berghaus G. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J Biol Chem 1990; 265: 18490-8
    PubMedGoogle Scholar
  • 41 Barnes DW, Reing J. Human spreading factor: Synthesis and response by HepG2 hepatoma cells in culture. J Cell Physiol 1985; 125: 207-14
    CrossrefPubMedGoogle Scholar
  • 42 Kubota K, Hayashi M, Oishi N, Sakaki Y. Polymorphism of the human vitronectin gene causes vitronectin blood type. Biochem Biophys Res Commun 1990; 167: 1355-60
    CrossrefPubMedGoogle Scholar
  • 43 Tollefsen DM, Weigel CJ, Kabeer MH. The presence of methionine or threonine at position 381 in vitronectin is correlated with proteolytic cleavage at arginine 379. J Biol Chem 1990; 265: 9778-81
    PubMedGoogle Scholar
  • 44 Podack ER, Müller-Eberhard HJ. Isolation of human S-protein, an inhibitor of the membrane attack complex of complement. J Biol Chem 1979; 254: 9908-14
    PubMedGoogle Scholar
  • 45 McGuire EA, Peacock ME, Inhorn R, Siegel NR, Tollefsen DM. Phosphorylation of vitronectin by a protein kinase in human plasma. J Biol Chem 1988; 263: 1942-5
    PubMedGoogle Scholar
  • 46 Korc-Grodzicki B, Tauber-Finkelstein M, Chain D, Shaltiel S. Vitronectin is phosphorylated by a cAMP-dependent protein kinase released by activation of human platelets with thrombin. Biochem Biophys Res Commun 1988; 157: 1131-8
    CrossrefPubMedGoogle Scholar
  • 47 Seiffert D, Wagner NN, Loskutoff DJ. Serum-derived vitronectin influences the pericellular distribution of type-1 plasminogenactivator inhibitor. J Cell Biol 1990; 111: 1283-91
    CrossrefPubMedGoogle Scholar
  • 48 Gebb C, Hayman EG, Engvall E, Ruoslahti E. Interaction of vitronectin with collagen. J Biol Chem 1986; 261: 16698-703
    PubMedGoogle Scholar
  • 49 Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 1987; 84: 6471-5
    CrossrefPubMedGoogle Scholar
  • 50 Preissner KT, Anders E, Grulich-Henn J, Müller-Berghaus G. Attachment of cultured human endothelial cells is promoted by specific association with S protein (vitronectin) as well as with the ternary S protein-thrombin-antithrombin III complex. Blood 1988; 71: 1581-9
    PubMedGoogle Scholar
  • 51 Dejana E, Colella S, Conforti G, Abbadini M, Gaboli M, Marchisio PC. Fibronectin and vitronectin regulate the organization of their respective Arg-Gly-Asp adhesion receptors in cultured endothelial cells. J Cell Biol 1988; 107: 1215-23
    CrossrefPubMedGoogle Scholar
  • 52 Lam SCT, Plow EF, D'Souza SE, Cheresh DA, Frelinger AL, Ginsberg MH. Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J Biol Chem 1989; 264: 3742-9
    PubMedGoogle Scholar
  • 53 Thiagarajan P, Kelly KL. Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 1988; 263: 3035-8
    PubMedGoogle Scholar
  • 54 Lawler J, Hynes O. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. Blood 1989; 74: 2022-7
    PubMedGoogle Scholar
  • 55 Plow EF, Ginsberg MH. Cellular adhesion: GPIIb-IIIa as prototypic adhesion receptor. Prog Hemoastas Thromb 1989; 9: 117-56
    PubMedGoogle Scholar
  • 56 Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffmann T. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest 1990; 83: 288-97
    PubMedGoogle Scholar
  • 57 Preissner KT, Zwicker L, Müller-Berghaus G. Formation, characterization and detection of a ternary complex between S protein, thrombin and antithrombin III in serum. Biochem J 1987; 243: 105-11
    CrossrefPubMedGoogle Scholar
  • 58 Bar-Shavit R, Sabbah V, Lampugnani MG, Marchisio PC, Fenton II JW, Vlodawsky I, Dejana E. An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion.. J Cell Biol 1990; (in press)
    PubMedGoogle Scholar
  • 59 Yatohgo T, Izumi M, Kashiwagi H, Hayashi M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct 1988; 13: 281-92
    CrossrefPubMedGoogle Scholar
  • 60 Lane DA, Flynn AM, Pejler G, Lindahl U, Choay J, Preissner KT. Structural requirements for the neutralization of heparin-like saccharides by complement S protein/vitronectin. J Biol Chem 1987; 262: 16343-9
    PubMedGoogle Scholar
  • 61 Loskutoff DJ, Sawdey M, Mimuro J. Type-1 plasminogen activator inhibitor. Prog Hemoastas Thromb 1989; 9: 87-115
    PubMedGoogle Scholar
  • 62 Levin EG, Santell L. Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells. J Cell Biol 1987; 105: 2543-9
    CrossrefPubMedGoogle Scholar
  • 63 Mimuro J, Schleef RR, Loskutoff DJ. Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood 1987; 70: 721-8
    PubMedGoogle Scholar
  • 64 Declerck PJ, De Mol M, Alessi M-C, Baudner S, Paques E-P, Preissner KT, Müller-Berghaus G, Collen D. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 1988; 263: 15454-61
    PubMedGoogle Scholar
  • 65 Wiman B, Almquist A, Sigurdardottir O, Lindahl T. Plasminogen activator inhibitor-1 (PAI) is bound to vitronectin in plasma. FEBS Lett 1988; 242: 125-8
    CrossrefPubMedGoogle Scholar
  • 66 Mimuro J, Loskutoff DJ. Purification of a protein from bovine plasma that binds to type-1 plasminogen-activator inhibitor and prevents its interaction with extracellular-matrix – evidence that the protein is vitronectin. J Biol Chem 1989; 264: 936-9
    PubMedGoogle Scholar
  • 67 Salonen E-M, Vaheri A, Pöllônen J, Stephens R, Andreasen P, Mayer M, Dano K, Gailit J, Ruoslahti E. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 1989; 264: 6339-43
    PubMedGoogle Scholar
  • 68 Mimuro J, Loskutoff DJ. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells. J Biol Chem 1989; 264: 5058-63
    PubMedGoogle Scholar
  • 69 Ehrlich HJ, Keijer J, Preissner KT, Klein Gebbink R, Pannekoek H. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin. Biochemistry 1991; 30: 1021-8
    CrossrefPubMedGoogle Scholar
  • 70 Ehrlich HJ, Klein Gebbink R, Keijer J, Linders M, Preissner KT, Pannekoek H. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties. J Biol Chem 1990; 265: 13029-35
    PubMedGoogle Scholar
  • 71 Radtke K-P, Wenz KH, Heimburger N. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Biol Chem Hoppe-Seyler 1990; 371: 1019-27
    PubMedGoogle Scholar
  • 72 Rovelli G, Stone SR, Preissner KT, Monard D. Specific interaction of vitronectin with the cell-secreted protease inhibitor glia-derived nexin (GDN) and the GDN-thrombin complex. Eur J Biochem 1990; 192: 797-803
    CrossrefPubMedGoogle Scholar
  • 73 Preissner KT. Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-indεced plasmin formation by tissue plasminogen activator. Biochem Biophys Res Commun 1990; 168: 966-71
    PubMedGoogle Scholar